Literature DB >> 26068611

Confocal scan laser ophthalmoscope for diagnosing glaucoma: a systematic review and meta-analysis.

Mohsen Yaghoubi1, Maziar Moradi-Lakeh, Mehdi Mokhtari-Payam, Ghasem Fakhraie, Farhad Shokraneh.   

Abstract

This systematic review was performed to estimate the diagnostic accuracy of the confocal scanning laser ophthalmoscopy in diagnosing glaucoma. We did a sensitive electronic search to find relevant studies. Two reviewers independently screened relevant articles and extracted required data about study methods and reported results of sensitivity and specificity. A meta-analysis was conducted for pooling data to compare different editions of the Heidelberg Retina Tomograph (HRT) with one of its alternatives, scanning laser polarimetry (GDx) with the criteria of "visual field defect" and "changes of nerve fiber layer" as the reference standard. We identified 37 evaluations from 28 relevant primary studies. In these studies, 9573 eyes (4883 glaucomatous and 4689 non-glaucomatous) were assessed with regards to the reference standard using one of the HRT editions with or without GDx. Diagnostic odds ratios were 9.35 [95% confidence interval (CI): 7.58-11.53] for HRT, 11.84 (95% CI: 9.97-14.06) for HRT II, 11.86 (95% CI: 9.16-15.35) for HRT III, and 21.33 (95% CI, 13.56-33.55) for GDx. Although GDx was more accurate than HRT, all editions of HRT had acceptable performance in diagnosing glaucomatous eyes with an ophthalmologist's clinical examination as the reference standard.

Entities:  

Mesh:

Year:  2015        PMID: 26068611     DOI: 10.1097/APO.0000000000000085

Source DB:  PubMed          Journal:  Asia Pac J Ophthalmol (Phila)        ISSN: 2162-0989


  2 in total

1.  Cost-effectiveness analysis of confocal scan laser ophthalmoscope (HRT II) versus GDX for diagnosing glaucoma.

Authors:  Mahdi Mokhtari-Payam; Maziar Moradi-Lakeh; Mohsen Yaghoubi; Mohammad Moradijou
Journal:  J Curr Ophthalmol       Date:  2015-11-18

2.  Photopic negative response of full-field electroretinography in patients with different stages of glaucomatous optic neuropathy.

Authors:  Marta Kirkiewicz; Wojciech Lubiński; Krzysztof Penkala
Journal:  Doc Ophthalmol       Date:  2016-01-29       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.